A detailed history of Fny Investment Advisers, LLC transactions in Vanda Pharmaceuticals Inc. stock. As of the latest transaction made, Fny Investment Advisers, LLC holds 5 shares of VNDA stock, worth $24. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5
Holding current value
$24
% of portfolio
0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 05, 2024

BUY
$3.91 - $6.5 $3,910 - $6,500
1,000 New
1,000 $5,000
Q1 2019

Apr 17, 2019

SELL
$17.59 - $31.05 $7,123 - $12,575
-405 Closed
0 $0
Q4 2018

Jan 22, 2019

BUY
$18.97 - $31.47 $7,682 - $12,745
405 New
405 $10,000
Q3 2018

Oct 29, 2018

SELL
$18.25 - $23.0 $3,102 - $3,910
-170 Closed
0 $0
Q2 2018

Jul 18, 2018

BUY
$13.95 - $19.15 $2,371 - $3,255
170 New
170 $3,000

Others Institutions Holding VNDA

About Vanda Pharmaceuticals Inc.


  • Ticker VNDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,561,500
  • Market Cap $271M
  • Description
  • Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...
More about VNDA
Track This Portfolio

Track Fny Investment Advisers, LLC Portfolio

Follow Fny Investment Advisers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fny Investment Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fny Investment Advisers, LLC with notifications on news.